Stellus Capital Investment Corporation 5.75% NT 2022 (SCA)

Svenska Cellulosa Aktiebolaget SCA (publ) (SCABY) Q4 2025 Earnings Call Transcript

/PRNewswire/ -- IBS Software today announced a multi-year Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS) to accelerate the

Svenska Cellulosa Aktiebolaget SCA (publ) (OTCPK:SCABY) Q3 2025 Earnings Call October 24, 2025 4:00 AM EDT Company Participants Anders Edholm - Senior Vice President of Sustainability & Communications Ulf Larsson - President, CEO & Director Andreas Ewertz - Chief Financial Officer Conference Call Participants Ioannis Masvoulas - Morgan Stanley, Research Division Linus Larsson - SEB, Research Division Charlie Muir-Sands - BNP Paribas Exane, Research Division Robin Santavirta - DNB Carnegie, Research Division Oskar Lindström - Danske Bank A/S, Research Division Martin Melbye - ABG Sundal Collier Holding ASA, Research Division Cole Hathorn - Jefferies LLC, Research Division Andrew Jones - UBS Investment Bank, Research Division Pallav Mittal - Barclays Bank PLC, Research Division Presentation Anders Edholm Senior Vice President of Sustainability & Communications Good morning, and welcome to this presentation of SCA's 2025 Third Quarter Results. With me here today, I have President and CEO, Ulf Larsson; and CFO, Andreas Ewertz, to go through the results and take your questions.

Paris, August 12, 2025 5:45 p.m. YOUR LEASING SOLUTION FOR SUSTAINABLE TRANSPORT Effective transfer of TOUAX SCA shares to Euronext Growth® Paris and delisting from the regulated market of Euronext Paris   TOUAX SCA (Ticker: TOUP, ISIN code: FR0000033003, the “Company”) announces today that the effective transfer of the listing of its shares to the Euronext Growth Paris market will take place on August 13, 2025.

PRESS RELEASE        Paris, June 12, 2025 5:45 PM YOUR LEASING SOLUTION FOR SUSTAINABLE TRANSPORT TOUAX SCA's Combined General Meeting of Shareholders approves the proposed transfer of listing from Euronext Paris to Euronext Growth Paris   TOUAX SCA announces that the Combined General Meeting of shareholders, held on 12 June 2025 at 3pm, approved, in accordance with the provisions of Article L. 421-14 of the French Monetary and Financial Code, the proposed transfer of the listing of its shares from the regulated market Euronext Paris, compartment C, to the market Euronext Growth Paris, and granted full powers to the Managing Partners to implement this transfer of listing, as set out in the 16th resolution.

REGULATED INFORMATION        Paris, May 7, 2025 5:45 PM YOUR LEASING SOLUTION FOR SUSTAINABLE TRANSPORT Proposal to transfer the listing of TOUAX shares from the Euronext Paris market to the Euronext Growth Paris market   At the Combined General Meeting to be held on June 12, 2025, the company TOUAX SCA will submit to the vote of its shareholders, in the sixteenth ordinary resolution, a proposal for the delisting of TOUAX SCA shares from Euronext Paris and their concomitant admission to trading on Euronext Growth Paris, as well as the authorization given to the Managing Partners to implement this market transfer, within 12 months of the General Meeting. Reasons for the transfer project This transfer would enable TOUAX SCA to be listed on a market more appropriate to its size and activity, and to simplify its operations by reducing the regulatory constraints and costs associated with listing on a regulated market, while continuing to benefit from the advantages of the financial markets.

BURLINGTON, Mass. , March 6, 2025 /PRNewswire/ -- Black Duck® Software, Inc. ("Black Duck"), a leading provider of application security solutions, today announced that STMicroelectronics (NYSE:STM), a global semiconductor leader serving customers across the spectrum of electronics applications, has successfully implemented Black Duck Software Composition Analysis (SCA) to streamline software bill of materials (SBOM) generation and strengthen its software security practices.

Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression on the primary and secondary outcome measures at the 3-year endpoint in a real-world evidence (RWE) study.

BHV-1300 achieved deep lowering of targeted IgG, with reductions > 60% in the lowest subcutaneous dose tested in the MAD. Subcutaneous BHV-1300 achieved rapid and progressive lowering of IgG within hours of each weekly dose administration, and pharmacodynamic effects were sustained relative to baseline over the four-week period.

Biohaven's pipeline progression includes Troriluzole for spinocerebellar ataxia [SCA], which has shown a 50-70% reduction in disease progression over three years. BHV-2100, a non-opioid migraine treatment, targets unmet needs in a market affecting 40 million U.S. patients and 1 billion globally. Taldefgrobep Alfa, under investigation for SMA and obesity, demonstrated subgroup-specific motor function improvements and favorable safety in Phase 3 trials.

Biohaven Ltd. reported positive results from a pivotal study using troriluzole for the treatment of patients with spinocerebellar ataxia; the Drug achieved 50% to 70% of slowing of disease progression over 3 years. With positive data on hand from the phase 3 study using troriluzole for patients with spinocerebellar ataxia, an NDA submission is planned for Q4 of 2024. Troriluzole is also being explored for patients with obsessive compulsive disorder in two phase 3 studies; Data from these studies are expected before the end of 2024 and the 1st half of 2025.

Troriluzole 200 mg dosed orally, once daily, in patients with SCA met the study's primary endpoint on the change from baseline in the modified functional Scale for the Assessment and Rating of Ataxia (f-SARA) at 3 years in all study population genotypes. Troriluzole also showed statistically significant superiority after both 1 and 2 years of treatment.

Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced a definitive agreement to acquire Carlisle Management Company SCA (“Carlisle”), a leading Luxembourg-based investment manager in the life settlement space, for approximately $200 million.

Pursuant to LVMH's liquidity contract with Oddo BHF SCA, on the 30th of June 2024 the following amounts appeared on the liquidity account.

Press Release VELIZY-VILLACOUBLAY, France — July 2, 2024 Half-year statement of the Liquidity contract entered into with Oddo BHF SCA Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) announces that the following resources appeared on June 30, 2023 on the liquidity contract entered into with Oddo BHF SCA implemented on January 7, 2015 and updated on June 18, 2019:       751,413.00 Dassault Systèmes shares, and €7,894,954.59 in cash. It is reminded that:       1.

Pursuant to LVMH's liquidity contract with Oddo BHF SCA, on the 31st of December 2023 the following amounts appeared on the liquidity account: